Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
QScreen AIPMEDF +47.68% EV-to-EBITDA is -7.17 as of Aug. 04, 2026. The stock has 1 warning sign investors should review. Among 512 Medical Devices & Instruments companies, QScreen AI ranks worse than 195312.3% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, QScreen AI's enterprise value is $6.06 Mil.
QScreen AI's EBITDA for the trailing twelve months (TTM) ended in Jan. 2026 was $-0.85 Mil. Therefore, QScreen AI's EV-to-EBITDA for today is -7.17.
The historical rank and industry rank for QScreen AI's EV-to-EBITDA or its related term are showing as below:
PMEDF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -7.17 Med: 0 Max: 0
Current: -7.17
PMEDF's EV-to-EBITDA is ranked worse than 100% of 512
companies
in the Medical Devices & Instruments industry
Industry Median: 14.37
vs PMEDF: -7.17
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
QScreen AI's share price for today is $0.02865.
QScreen AI's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.004.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for QScreen AI's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, QScreen AI's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
QScreen AI EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, QScreen AI's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where QScreen AI's EV-to-EBITDA falls into.
QScreen AI's current Enterprise Value is $6.06 Mil.
QScreen AI's EBITDA for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.85 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
QScreen AI (PMEDF) has a EV-to-EBITDA of -7.17 as of Aug. 04, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on QScreen AI. According to the industry distribution chart, QScreen AI ranks #999999 out of 512 companies in the Medical Devices & Instruments industry.
Is QScreen AI's EV-to-EBITDA too high?
QScreen AI's current EV-to-EBITDA is -7.17. Based on the distribution chart, QScreen AI ranks #999999 out of 512 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does QScreen AI's EV-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, QScreen AI ranks #999999 out of 512 companies for EV-to-EBITDA. This places QScreen AI in the lower half of its industry. The industry median EV-to-EBITDA is 14.37. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.37, based on 512 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on QScreen AI. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. QScreen AI's current EV-to-EBITDA is -7.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QScreen AI stock overvalued right now?
QScreen AI (PMEDF) has a current EV-to-EBITDA of -7.17. The current EV-to-EBITDA is -7.17. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For QScreen AI (PMEDF), the current EV-to-EBITDA is -7.17 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
QScreen AI Inc is focused on developing artificial intelligence (AI) powered technologies for general workplace health and safety, and for the health care industry. The company's business is focused on artificial intelligence (AI) technologies targeting two specific areas: workplace health and safety and healthcare. It is building a proprietary artificial intelligence engine with quantum inspired computing and physiological sensing to clinical and occupational health assessments across correctional facilities, addiction medicine rehabilitation, and industrial workforce screening in multiple jurisdictions. It operates in single segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PMEDF has been successfully added to your 
